Raised hep C awareness lead to 10% rise in England diagnosis

24 December 2007

The number of newly-diagnosed cases of hepatitis C infection in England reached 8,346 in 2006 - 10% higher than in 2005, according to latest figures released by the Health Protection Agency. The HPA's annual report for 2007 on hepatitis C suggests that the effort to raise awareness of the disease is encouraging more people to be tested.

There has been a considerable increase in the attention paid to hepatitis C over the last 12 months. This follows the launch of a National Health Service campaign aimed at health care professionals and the public, which saw visits to the NHS web site (www.hepc.nhs.uk) and Hepatitis C Information Line more than double. The late Dame Anita Roddick, who was diagnosed with hepatitis C and campaigned until her death to raise awareness and to encourage people to get tested, undoubtedly made a significant contribution to the increase in media coverage about hepatitis C, notes the HPA.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight